Depression associated with medical illness: Treatment considerations

CNS Drugs

Volumn 5, Issue 3, 1996, Pages 175-189

  Fava, Giovanni A ^a   Sonino, Nicoletta ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

DEPRESSION; HUMAN; PHYSICAL DISEASE; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW;

EID: 0029962821     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199605030-00004     Document Type: Review

References (127)

1. Fava GA. Depression in medical settings. In: Paykel ES, editor. Handbook of affective disorders. 2nd ed. Edinburgh: Churchill Livingstone, 1992: 667-85
2. Rodin G, Craven J, Littlefield C. Depression in the medically ill. New York: Brunner-Mazel, 1991
3. Lipowski ZJ. Physical illness and psychopathology. Int J Psychiatry Med 1974; 5: 483-97
4. Avery D, Winokur G. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry 1976; 33: 1029-37
5. Kellner R. Psychosomatic syndromes, somatization and somato-form disorders. Psychother Psychosom 1994; 61: 4-24
6. Emmelkamp PMG, van Oppen P. Cognitive interventions in behavioral medicine. Psychother Psychosom 1993; 59: 116-30
7. Ananth J. Psychopharmacological agents in physical disorders. Psychother Psychosom 1992; 58: 13-31
8. Mayou R, Smith EOP. Hospital doctors' management of psychological problems. Br J Psychiatry 1986; 148: 194-7
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
10. Paykel ES, Hollyman JA, Freeling P, et al. Predictors of therapeutic benefit from amitriptyline in mild depression. J Affect Dis 1988; 14: 83-95
11. Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med 1989; 149: 1785-9
12. Grandi S, Fava GA, Cunsolo A, et al. Rating depression and anxiety after mastectomy. Int J Psychiatry Med 1990; 20: 163-71
13. Fava GA, Sonino N, Wise TN. Management of depression in medical patients. Psychother Psychosom 1988; 49: 81-102
14. Cavanaugh SA. Depression in the medically ill. Psychosomatics 1995; 36: 48-59
15. World Health Organization. The ICD-10 classification of mental and behavioural disorders. Geneva: World Health Organization, 1992
16. Fava GA, Freyberger HJ, Bech P, et al. Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995; 63: 1-8
17. Sonino N, Fava GA, Belluardo P, et al. Course of depression in Cushing's syndrome: response to treatment and comparison with Graves' disease. Horm Res 1993; 39: 202-6
18. Fava GA, Sonino N, Morphy MA. Psychosomatic view of endocrine disorders. Psychother Psychosom 1993; 59: 20-33
19. Whitlock FA. Symptomatic affective disorders. Sydney: Academic Press, 1982
20. Cummings JL. Depression and Parkinson's disease. Am J Psychiatry 1992; 149: 443-54
21. Brown RG, MacCarthy B, Gotham AM, et al. Depression and disability in Parkinson's disease. Psychol Med 1988; 18: 49-55
22. Jouvent R, Abensour P, Bonnet AM, et al. Antiparkinsonian and antidepressant effects of high doses of bromocriptine. J Affect Dis 1983; 5: 141-5
23. Andersen J, Aabro E, Gulman N, et al. Antidepressive treatment in Parkinson's disease. Acta Neurol Scand 1980; 62: 210-9
24. Starkstein SE, Robinson RG. Affective disorder and cerebral vascular disease. Br J Psychiatry 1989; 154: 170-82
25. Sharpe M, Hawton K, Seagrott V, et al. Depressive disorders in long-term survivors of stroke. Br J Psychiatry 1994; 164: 380-6
26. Lipsey JR, Robinson RG, Pearlson GD, et al. Nortriptyline treatment of post-stroke depression. Lancet 1985; i: 297-300
27. Reding MJ, Orto LA, Winter SW, et al. Antidepressant therapy after stroke. Arch Neurol 1986; 43: 763-5
28. Murray GB, Shea V, Conn DK. Electroconvulsive therapy for post-stroke depression. J Clin Psychiatry 1987; 47: 258-60
29. Folstein SE, Abbott MH, Chase GA, et al. Huntington's disease in a case series and in a family. Psychol Med 1983; 13: 537-42
30. Ford MF. Treatment of depression in Huntington's disease with monoamine oxidase inhibitors. Br J Psychiatry 1986; 149: 654-6
31. Lishman WA. Organic psychiatry. Oxford: Blackwell, 1987
32. Berrios GE, Quemada JI. Depressive illness in multiple sclerosis. Br J Psychiatry 1990; 156: 10-6
33. Larcombe NA, Wilson PH. An evaluation of cognitive behavior therapy for depression in patients with multiple sclerosis. Br J Psychiatry 1984; 145: 366-71
34. Schiffer RB, Wineman NM. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 1990; 147: 1493-7
35. Schiffer RB, Herndon RM, Rudick RA. Treatment of pathological laughing and weeping with amitriptyline. N Engl J Med 1985; 312: 1480-2
36. Robertson MM, Trimble MR, Townsend HRA. Phenomenology of depression in epilepsy. Epilepsia 1987; 28: 364-72
37. Robertson MM, Trimble MR. The treatment of depression in patients with epilepsy. J Affect Dis 1985; 9: 127-36
38. Saran AS. Depression after minor closed head injury. J Clin Psychiatry 1985; 46: 335-8
39. Reifler BV, Teri L, Raskind M, et al. Double-blind trial with imipramine in Alzheimer's disease patients with and without depression. Am J Psychiatry 1989; 146: 45-9
40. Ananth J, Swartz R, Burgoyne K, et al. Hepatic disease and psychiatric illness. Psychother Psychosom 1994; 62: 146-59
41. Hama N, Boumpas DT. Cerebral lupus erythematosus. CNS Drugs 1995; 3: 416-26
42. Eilenberg MD. Psychiatric illness and pernicious anemia. J Ment Sci 1960; 106: 1539-48
43. Holland JC, Korzym AN, Tross S, et al. Comparative psychological disturbance in patients with pancreatic and gastric cancer. Am J Psychiatry 1986; 143: 982-6
44. Hughes JE. Depressive illness and lung cancer. Eur J Surg Oncol 1985; 11: 15-20
45. Perkins D, Evans DL. HIV-related major depression. Psychosomatics 1991; 32: 451-4
46. Judd FK, Mijch AM. Depression in patients with HIV and AIDS. Aust NZ J Psychiatry 1994; 28: 642-50
47. Rabkin JG, Rabkin R, Harrison W, et al. Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV infection. Am J Psychiatry 1994; 151: 516-23
48. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed., rev. Washington, DC: American Psychiatric Association, 1987
49. Winokur G, Black DW, Nasrallah A. Depressions secondary to other psychiatric disorders and medical illness. Am J Psychiatry 1988; 145: 233-7
50. Feldman B, Mayou R, Hawton K, et al. Psychiatric disorder in medical in-patients. Q J Med 1987; 63: 405-12
51. Fava GA, Morphy MA, Sonino N. Affective prodromes of medical illness. Psychother Psychosom 1994; 62: 141-5
52. Edwards GJ. Drug-related depression. In: Herbst KR, Paykel ES, editors. Depression. Oxford: Heinemann, 1989: 81-108
53. Zelnik T. Depressive effects of drugs. In: Cameron OG, editor. Presentations of depression. New York: Wiley, 1987: 355-99
54. Beers MH, Passman LJ. Antihypertensive medications and depression. Drugs 1990; 40: 792-9
55. Schleifer SJ, Slater WR, Macari-Hinson MM, et al. Digitalis and beta-blocking agents. Am Heart J 1991; 121: 1397-402
56. Sonino N. The use of ketoconazole as an inhibitor of steroid production. N Engl J Med 1987; 317: 812-8
57. Detre TP, Jarecki HJ. Modern psychiatric treatment. Philadelphia: Lippincott, 1971
58. Fava GA, Kellner R. Staging. Acta Psychiatr Scand 1993; 87: 225-30
59. Travella JI, Forrester AW, Schultz SK, et al. Depression following myocardial infarction. Int J Psychiatry Med 1994; 24: 357-69
60. Costa D, Mogos I, Toma T. Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatr Scand 1985; 72 Suppl. 320: 85-92
61. Rifkin A, Reardon G, Siris S, et al. Trimipramine in physical illness with depression. J Clin Psychiatry 1985; 46 (2 Pt 2): 4-8
62. Lakshmanan M, Mion LC, Frengley JD. Effective low-dose tricyclic antidepressant treatment for depressed geriatric rehabilitation patients. J Am Geriatr Soc 1986; 34: 421-6
63. Borson S, McDonald GJ, Gayle T, et al. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 1992; 33: 190-201
64. Schwartz JA, Speed M, Beresford TP. Antidepressants in the medically ill. Int J Psychiatry Med 1989; 19: 363-9
65. Popkin MK, Callies AL, MacKenzie TB. The outcome of antidepressant use in the medically ill. Arch Gen Psychiatry 1985; 42: 1160-3
66. Laux G, Volz HP, Moller HJ. Newer and older monoamine oxidase inhibitors: a comparative profile. CNS Drugs 1995; 3: 145-58
67. Masand P, Pickett P, Murray GB. Psychostimulants for secondary depression in medical illness. Psychosomatics 1991; 32: 203-8
68. Wallace AE, Kofoed LL, West AN. Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medical patients. Am J Psychiatry 1995; 152: 929-31
69. Satel SL, Nelson JC. Stimulants in the treatment of depression. J Clin Psychiatry 1989; 50: 241-9
70. Blackwell B. Newer antidepressant drugs. In: Meltzer HY, editor. Psychopharmacology. New York: Raven Press, 1987: 1041-9
71. Hollister LE. New psychotherapeutic drugs. J Clin Psychopharmacol 1994; 14: 50-63
72. Carroll BJ. Neurobiologic dimensions of depression and mania. In: Angst J, editor. The origins of depression. Berlin: Springer, 1983: 163-86
73. Bech P. Acute therapy of depression. J Clin Psychiatry 1993; 54 (8 Suppl.): 18-27
74. Huyse FJ, Zwaan WA, Kupka R. The applicability of antidepressants in the depressed medically ill: an open clinical trial with fluoxeline. J Psychosom Res 1994; 7: 695-703
75. Roose SP, Glassman AH, Attia E, et al. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151: 1735-9
76. Lasagna L. Some adverse interactions with other drugs. In: Lipton MA, Di Mascio A, Killam KF, editors. Psychopharmacology. New York: Raven Press, 1978: 1005-8
77. Borg S, Brodin K. Antidepressant drugs. In: Dukes MNG, editor. Meyler's side effects of drugs. Amsterdam: Elsevier, 1992: 30-78
78. Preskorn SH, Magnus RD. Inhibition of hepatic P-450 isoenzymes by serotonin selective reuptake inhibitors. Psychopharmacol Bull 1994; 30: 251-9
79. Siris SG, Rifkin A. The problem of psychopharmacotherapy in the medically ill patients. Psychiatr Clin North Am 1981; 4: 379-90
80. Muskin PR, Glassman AH. The use of tricyclic antidepressants in a medical selling. In : Finkel JB, editor. Consultation - liason psychiatry. New York: Grune and Stratton, 1983: 137-58
81. Fava GA. Diagnosis and treatment of depression in the medically ill. Prog Neuropsychopharmacol Biol Psychiatry 1986; 10: 1-9
82. Amdisen A, Hildebrandt J. Use of lithium in the medically ill. Psychother Psychosom 1988; 49: 103-19
83. Series HG. Drug treatment of depression in medically ill patients. J Psychosom Res 1992; 36: 1-16
84. Ananth J, Johnson K. Psychotropic and medical drug interactions. Psychother Psychosom 1992; 58: 178-96
85. Spina E, Perucca E. Newer and older anlidepressants: a comparative review of drug interactions. CNS Drugs 1994; 2: 479-97
86. Ciraulo DA, Shader RI, Greenblatt DJ, et al., editors. Drug interactions in psychiatry. Baltimore: Williams and Wilkins, 1988
87. Silver PA, editor. Psychotropic drug use in the medically ill. Basel: Karger, 1994
88. Pirmohamed M, Kitteringham NR, Park BK. Idiosyncratic reactions to antidepressants. Pharm Ther 1992; 53: 105-25
89. Glassman AH, Stage KB. Depressed patients with cardiovascular disease: treatment considerations. CNS Drugs 1994; 1: 435-40
90. Marti V, Ballester M, Udina C, et al. Evaluation of myocardial damage by In-111-monoclonal antimyosin antibodies in patients under chronic tricyclic antidepressant drug treatment. Circulation 1995; 91: 1619-23
91. Skowron DM, Stimmel GL. Antidepressants and the risk of seizures. Pharmacotherapy 1992; 12: 18-22
92. Tyber MA. The relationship between hiatus hernia and tricyclic antidepressants. Am J Psychiatry 1975; 132: 652-3
93. Malone DA, Camara EG, Krug JH. Ophthalmologic effects of psychotropic medications. Psychosomatics 1992; 33: 271-7
94. Levy NB. Use of psychotropics in patients with kidney failure. Psychosomatics 1985; 26: 699-709
95. Brady KT, Lydiard RB, Kellner CH, et al. A comparison of the effects of imipramine and fluvoxamine on the thyroid axis. Biol Psychiatry 1994; 36: 778-9
96. Achong MR, Keane PM. Pheochromocytoma unmasked by desipramine therapy. Ann Intern Med 1981; 94: 358-9
97. Goodnick PJ, Henry JH, Buki VMV. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 1995; 56: 128-36
98. Elphick M. Antidepressant drugs. In: Dukes MGN, Aronson JK, editors. Side effects of drugs, Annual 16. Amsterdam: Elsevier, 1993: 7-12
99. Boakes AJ, Laurence DR, Teoh PC, et al. Interactions between sympathomimetic amines and antidepressant agents in man. BMJ 1973; i: 311-5
100. Kodar D. Amitriptyline and isoproterenol: fatal drug combination. Can Med Assoc J 1975; 112: 556-7
101. Wilson IC, Prange AJ, Lara PP. Methyltestosterone with imipramine in men. Am J Psychiatry 1974; 131: 21-4
102. True BL, Perry BJ, Burns EA. Profound hypoglycemia with addition of tricyclic antidepressants to maintenance sulfonylurea therapy. Am J Psychiatry 1987; 144: 1220-1
103. Morgan JP, Rivera-Calimlim L, Messiha F, et al. Imipramine-mediated interference with levodopa absorption from the gastrointestinal tract in man. Neurology 1975; 25: 1029-34
104. Robbins LJ. Dry month and delayed dissolution of sublingual nitroglycerin [letter]. N Engl J Med 1983; 309: 985
105. Rubinstein G, McIntyre I, Burrows GD, et al. Metabolism of tricyclic antidepressant drugs. In: Burrows GD, Norman TR, Davies B, editors. Antidepressants. New York: Elsevier, 1983: 57-74
106. Bint A, Burtt I. Adverse antibiotic drug interactions. Drugs 1980; 20: 57-68
107. Kosanin R. Anesthetic considerations in patients on chronic tricyclic antidepressant therapy. Anesthesiol Rev 1981; 8: 38-41
108. Massie MJ, Holland JC. Diagnosis and treatment of depression in the cancer patient. J Clin Psychiatry 1984; 45 (3 Pt 2): 25-8
109. Blashki TG, Mowbray R, Davies B. Controlled trial of amitriptyline in general practice. BMJ 1971; i: 133-8
110. Wilkinson GR, Shand DG. A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 1975; 18: 377-90
111. Piafsky KM, Borga O. Plasma protein binding of basic drugs. Clin Pharmacol Ther 1977; 22: 545-9
112. Preskorn SH. Pharmacokinetics of antidepressants: why and how they are relevant to treatment. J Clin Psychiatry 1993; 54 (9 Suppl.): 14-34
113. Molnar G, Gupta RN. Plasma levels and tricyclic antidepressant therapy. Part 2. Biopharm Drug Dispos 1980; 1: 283-305
114. Riedel WJ, van Praag HM. Avoiding and managing anticholinergic effects of antidepressants. CNS Drugs 1995; 3: 245-59
115. Hollon S, Shelton RC, Davis DD. Cognitive therapy for depression. J Consult Clin Psychol 1993; 61: 270-5
116. Fava GA, Grandi S, Zielezny M, et al. Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 1994; 151: 1295-9
117. Steinmuller RI. Psychotherapeutic treatment planning in the medically ill. In: Karasu TB, Steinmuller RI, editors. Psychotherapeutics in medicine. New York: Grune and Stratton, 1978: 35-62
118. Kelly JA, Murphy DA, Bahr GR, et al. Outcome of cognitive-behavioral and support group brief therapies for depressed. HIV-infected persons. Am J Psychiatry 1993; 150: 1679-86
119. Thompson DR. A randomized controlled trial of in-hospital nursing support for first time myocardial infarction patients and their partners. J Adv Nurs 1989; 14: 291-7
120. Blumenthal JA, Williams RS, Wallace AG, et al. Physiologic and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom Med 1982; 44: 519-27
121. Agle DP, Baum GL, Chester EH, et al. Multidiscipline treatment of chronic pulmonary insufficiency. Psychosom Med 1973; 35: 41-9
122. Morgan AD, Peck DF, Buchanan DR, et al. Effect of attitudes and beliefs on exercise tolerance in chronic bronchitis. BMJ 1983; 286: 171-3
123. Teasdale JD, Fennell MJV, Hibbert GA, et al. Cognitive therapy for major depressive disorder in primary care. Br J Psychiatry 1984; 144: 400-6
124. Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, et al. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 1995; 310: 441-5
125. Zwil AS, Pelchat RJ. ECT in the treatment of patients with neurological and somatic disease. Int J Psychiatry Med 1994; 24: 1-29
126. Sackheim HA, Devamand DP, Nobler MS. Electroconvulsive therapy. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology. New York: Raven Press, 1995: 1123-41
127. Zielinski RJ, Roose SP, Devanand DP, et al. Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry 1993; 150: 904-9